DrugPatentWatch Database Preview
MENRIUM 5-2 Drug Profile
When do Menrium 5-2 patents expire, and what generic alternatives are available?
Menrium 5-2 is a drug marketed by Roche and is included in one NDA.
The generic ingredient in MENRIUM 5-2 is chlordiazepoxide; estrogens, esterified. There are nine drug master file entries for this compound. Additional details are available on the chlordiazepoxide; estrogens, esterified profile page.
Summary for MENRIUM 5-2
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | MENRIUM 5-2 at DailyMed |
US Patents and Regulatory Information for MENRIUM 5-2
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | MENRIUM 5-2 | chlordiazepoxide; estrogens, esterified | TABLET;ORAL | 014740-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MENRIUM 5-2
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Roche | MENRIUM 5-2 | chlordiazepoxide; estrogens, esterified | TABLET;ORAL | 014740-002 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
